̽»¨Ö±²¥

Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge ̽»¨Ö±²¥Â for more than two decades. What are the secrets of their success?

A new institute at the ̽»¨Ö±²¥ of Cambridge aims to revolutionise cancer care by using cutting edge analytics to maximize the use of big data sets collected from patients.

Cancer Research UK (CRUK) has today announced funding for a new Children’s Brain Tumour Centre of Excellence, based at the ̽»¨Ö±²¥ of Cambridge and ̽»¨Ö±²¥Institute of Cancer Research, London.

̽»¨Ö±²¥Cancer Research UK Cambridge Centre has become the first UK institute to be designated a Comprehensive Cancer Center of Excellence by the European Academy of Cancer Sciences (EACS).

Nine researchers from the ̽»¨Ö±²¥ of Cambridge are among 46 world leading UK researchers who have been elected to the prestigious Fellowship of the Academy of Medical Sciences.

Cambridge scientists are set to receive a major cash injection from Cancer Research UK, which has announced plans to invest over £41 million over the next five years at the Cancer Research UK Cambridge Centre, one of the ̽»¨Ö±²¥ of Cambridge’s Strategic Research Initiatives. ̽»¨Ö±²¥funding will help support ground-breaking work as part of the development of a unique chain of research hubs around the UK.

Thirty years ago, Professor Richard Gilbertson pledged to implement a 15 per cent reduction in mortality from children’s brain cancer. This is the story of what happened next.

Interview: Lucy Jolin​

̽»¨Ö±²¥ ̽»¨Ö±²¥ of Cambridge has received an additional £5 million over two years from Cancer Research UK for the launch of a ‘Major Centre’, focused on integrative cancer medicine and early detection.

One of the world’s leading childhood brain tumour experts, Professor Richard Gilbertson, has been appointed as Li Ka Shing Chair of Oncology in Cambridge and Director of the Cambridge Cancer Centre. He will take up his appointment in August.